Determinants of Accrual to Prostate Cancer Clinical Trials

References

• NCIC. National Cancer Institute of Canada: Canadian Cancer Statistics 2002. (2002) Toronto, National Cancer Institute of Canada. Ref Type: Report.
   Google Scholar
• Lara , P.N. , Higdon , R. , Lim , N. , Kwan , K. , Tanaka , M. Lau , D.H.M. 2001 . “Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrolment” . J. Clin. Oncol. , 19 : 1728 – 1733 .
   PubMed Web of Science ®Google Scholar
• Denis , L. , Norlen , B.I. , Holmberg , L. , Begg , C.B. , Damber , J.E. and Wilt , T.J. 1997 . “Planning controlled clinical trials. Prostatic cancer” . Urology , 49 : 15 – 26 .
   Google Scholar
• Schellhammer , P. , Cockett , A. Boccon-Gibod , L. 1997 . “Assessment of endpoints for clinical trials for localized prostate cancer” . Urology , 49 : 27 – 38 .
   PubMed Web of Science ®Google Scholar
• Wilt , T.J. 1998 . “Can randomized treatment trials in early stage prostate cancer be completed? [editorial]” . Clin. Oncol. (R. Coll. Radial) , 10 : 141 – 143 .
   Google Scholar
• Willis , R.G. 1999 . “Patients with prostate cancer should be enrolled in a national, controlled trial [letter]” . Br. Med. J. , 318 : 126
   Google Scholar
• Johansen , M.A. , Mayer , D.K. and Hovver , H.C.J. 1991 . 'Obstacles to implementing cancer clinical trials” . Semin. Oncol. Nurs. , 7 : 260 – 267 .
   PubMedGoogle Scholar
• Yusuf , S. , Held , P. and Toretsky , E.R. 1990 . “Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria” . Slot. Med. , 9 : 73 – 83 .
   Google Scholar
• Bensen , A.B. , Pregler , J.P. , Bean , I.A. , Rademaker , A.W. , Eshler , B. and Anderson , K. 1991 . “Oncologists' reluctance to accrue patients onto clinical trials: an Illinois cancer center study” . J. Clin. Oncol. , 7 : 260 – 267 .
   Google Scholar
• Foley , J.F. and Moertel , C.G. 1991 . “Improving accrual into cancer clinical trials” . J. Cancer Educ. , 6 : 165 – 173 .
   PubMedGoogle Scholar
• Gotay , CC. 1991 . “Accrual to cancer clinical trials: directions from the research literature” . Soc. Sci. Med. , 33 : 569 – 577 .
   PubMed Web of Science ®Google Scholar
• Bevan , E.G. , Chee , L.C. , McGhee , S.M. and McInnes , G.T. 1993 . “Patients' attitudes to participation in clinical trials” . Br. J. Clin, Pharmacol. , 35 : 204 – 207 .
   PubMed Web of Science ®Google Scholar
• Lasagna , L. and Frei , E. 1996 . “The impact of regulations, tradition, and experimental design on clinical cancer trials: report and recommendations resulting from Washington Cancer Trials Conference” . Am. J. Clin. Oncol. , 19 : 325 – 329 .
   Google Scholar
• Grant , C.H. , Cisna , K.N. and Rosenfeld , L.B. 2000 . “Patient's perception of physicians communication and outcomes of the accrual to trial process” . Health Commun. , 12 : 23 – 29 .
   PubMed Web of Science ®Google Scholar
• Jenkins , V. and Fallowfield , L. 2000 . “Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy” . Br. J. Cancer , 82 : 1783 – 1788 .
   PubMed Web of Science ®Google Scholar
• Begg , C.B. 1987 . “Cancer clinical trails in the USA: patient eligibility, generalizability of results and technology transfer” . Bull. Cancer , 74 : 197 – 203 .
   Google Scholar
• McCusker , J. , Wax , A. and Bennet , J.M. 1984 . “Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry” . Am. J. Clin. Oncol. , 5 : 227 – 236 .
   Google Scholar
• Martin , I.F. , Henderson , W.G. Zacharski , L.R. 1984 . “Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies” . Am. J. Clin. Oncol. , 7 : 173 – 182 .
   PubMed Web of Science ®Google Scholar
• Hunter , C.P. , Frelick , R.W. Feldman , A.R. 1987 . “Selection factors in clinical trials: results from the Community clinical oncology program physician's patient log” . Cancer Treat. Rep. , 71 : 559 – 565 .
   PubMedGoogle Scholar
• Klabunde , C.N. , Springer , B.C. , Butler , B. , White , M.S. and Atkins , J. 1999 . “Factors influencing enrolment in clinical trials for cancer treatment” . South Med. J. , 92 : 1189 – 1193 .
   PubMed Web of Science ®Google Scholar
• Choo , R. , Klotz , L. , Danjoux , C. , Mortem , G. , DeBoer , G. Szumacher , E. 2002 . “Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression” . J. Urol. , 167 : 1664 – 1669 .
   PubMedGoogle Scholar
• Carroll , PR. , Lee , K.L. , Fuks , Z.Y. and Kantoff , P.W. 2001 . “Cancer of the Prostate” . In Cancer: Principles and Practice of Oncology, , 6th Ed. , Edited by: DeVita , V.T. , Hellman , S. and Rosenberg , S.A. Philadelphia : Lippincott Williams & Wilkins .
   Google Scholar
• George , S.L. 1996 . “Reducing patient eligibility criteria in cancer clinical trials” . J. Clin. Oncol. , 14 : 1364 – 1370 .
   Google Scholar
• Fuks , A. , Weijer , C. , Freedman , B. , Shaprio , S. , Skrutkowska , M. and Riaz , A. 1998 . “A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. (National Surgical Adjuvant Breast and Bowel Program, Pediatric Oncology Group.)” . J. Clin. Epidemiol , 51 : 69 – 79 .
   PubMed Web of Science ®Google Scholar
• Siminoff , L.A. , Zhang , A. , Colabianchi , N. , Saunders Strum , C.M. and Shen , Q. 2000 . “Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists” . J. Clin. Oncol. , 18 : 1203 – 1211 .
   PubMed Web of Science ®Google Scholar
• Larson , E. and McGuire , D.B. 1990 . “Patient experiences with research in a tertiary care setting” . Nurs. Res. , 39 : 168 – 171 .
   Google Scholar
• Coalition of the National Cancer Cooperative Groups, Cancer Research Foundation of America Cancer leadership Council and Oncology Nursing Society , Comis , R. , Aldige , C. , Stovall , E. , Krebs , L. , Risher , P. and Taylor , H. 2000 . A Quantitative Survey of Public Attitudes Towards Cancer Clinical Trials , New York , NY : Harris Interactive Inc. .
   Google Scholar
• Simon , M.S. , Brown , D.S. , Du , W. , LoRosso , P. and Kellogg , M. 1999 . “Accrual to breast cancer clinical trials at a university-affiliated hospital in metropolitan Detroit” . Am. J. Clin. Oncol. , 22 : 42 – 46 .
   PubMed Web of Science ®Google Scholar
• Maslin , A. 1994 . “A survey of the opinions on 'informed consent' of women currently involved in clinical trials within a breast unit” . Eur. J. Cancer Care (Engl.) , 3 : 153 – 162 .
   PubMedGoogle Scholar
• Ellis , P.M. 2000 . “Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature” . Ann. Oncol. , 11 : 939 – 945 .
   PubMed Web of Science ®Google Scholar
• Bujorian , G.A. 1988 . “Clinical trials: patient issues in the decision-making process” . Oncol. Nurs. Forum. , 15 : 779 – 783 .
   PubMedGoogle Scholar